Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cayman
PAD4 (human, recombinant)
CHF 0.00
In stock
CAY-10500-100100 µgCHF 776.00
CAY-10500-11 mgINQ
| Product Details | |
|---|---|
| Synonyms | PADI4; PADI5; PDI5; Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4 |
| Product Type | Protein |
| Properties | |
| Sequence | Active recombinant human N-terminal His-tagged PAD4 expressed in E. coli. |
| Purity | ≥85% (SDS-PAGE) |
| Formulation | 50 mM HEPES, pH 8.0, containing 300 mM sodium chloride, 1 mM DTT, and 10% glycerol |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| Declaration | Manufactured by Cayman Chemicals. |
| Shipping and Handling | |
| Shipping | DRY ICE |
| Long Term Storage | -80°C |
| Documents | |
| MSDS | Inquire |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
PAD4 is a homodimer that functions as a transcriptional coregulator to catalyze the conversion of specific arginine residues to citrulline in a calcium-dependent manner. PAD4 substrates include histones H2A, H3, and H4, whose post-translational modifications play a large role in gene regulation.